RAD
Price sensitive
RAD101 2nd interim Ph.2b data - 90% achieve primary endpoint
Radiopharm Theranostics Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in